Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder [Phase 3]
A Phase 3 clinical trial comparing duloxetine hydrochloride, a marketed comparator, and placebo for generalized anxiety disorder has complet…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder [Phase 3]
This document reports the completion of a Phase 3 trial comparing duloxetine with placebo in adults with generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2007-10-18Clinical Trial Update: A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder [Phase 3]
Phase 3 trial comparing duloxetine hydrochloride, a marketed comparator, and placebo for generalized anxiety disorder has completed.
-
FDA approval · 2007-09-20FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2007-08-31Clinical Trial Update: Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder [Phase 3]
This Phase 3 study compared duloxetine to placebo for relapse prevention in generalized anxiety disorder and has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-08-01FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The action pertai…
-
FDA approval · 2007-07-25FDA Approved: PAROXETINE — Original Application (NorthStar Rx LLC)
FDA approves NorthStar Rx LLC's original ANDA for paroxetine hydrochloride (generic paroxetine).
-
FDA approval · 2007-07-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc. The approval updates t…
-
FDA approval · 2007-07-11FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental ANDA for doxepin hydrochloride from Mylan Pharmaceuticals Inc., enabling a generic version of the drug to en…
-
FDA approval · 2007-06-26FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for doxepin hydrochloride from Lannett Company, Inc., authorizing changes to an already approved pro…
-
FDA approval · 2007-06-21FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis (Pfizer) to update the labeling with expanded o…
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Treatment for Anxiety in Children [Phase 3]
A Phase 3 clinical trial evaluating a treatment for anxiety disorders in children has completed. The study covered obsessive-compulsive diso…
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Duloxetine vs Placebo in the Treatment of General Anxiety [Phase 3]
A Phase 3 trial comparing duloxetine to placebo for generalized anxiety disorder has completed.
-
FDA approval · 2007-03-16FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for buspirone hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2007-03-07FDA Approved: PAROXETINE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original application for paroxetine hydrochloride tablets (generic paroxetine). This approval prov…
-
FDA approval · 2007-02-13FDA Approved: ALPRAZOLAM EXTENDED RELEASE — Original Application (Actavis Pharma, Inc.)
FDA approved a generic alprazolam extended-release tablet (Actavis) via Original Application, adding another market option for anxiety and p…
-
FDA approval · 2007-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for paroxetine hydrochloride as a generic product. Paroxetine is used to treat maj…
-
FDA approval · 2006-11-29FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lorazepam by Hikma Pharmaceuticals USA Inc., authorizing modifications under the supplement.
-
FDA approval · 2006-09-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Study of Risperidone Monotherapy in Bipolar Anxiety [Phase 4]
Phase 4 trial of risperidone monotherapy for bipolar anxiety has completed, examining efficacy in bipolar disorder with co-occurring panic o…
-
FDA approval · 2006-08-22FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2006-08-22FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Paroxetine hydrochloride submitted by Apotex Corp.
-
FDA approval · 2006-08-03FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's venlafaxine hydrochloride as an original ANDA, making a generic version of venlafaxine hydrochloride available.